Dexamethasone induced lupus miliaris disseminatus faciei : a case repor

Abstract

Dexamethasone induced lupus miliaris disseminatus faciei : a case report

Abstract

References

1. ) el Darouti M, Zaher H: Lupus miliaris disseminatus faciei- pathologic study of early, fully developed, and late lesions. Int J Dermatol. 32:508-511, 1993.
2. ) Shitara A: Lupus miliaris disseminatus faciei. Int J Dermatol. 23:542-544, 1984.
3. ) Walchner M, Plewing G, Messer G: Lupus miliaris disseminatus faciei evoked during pregnancy in a patient with cutaneous lupus erythematosus. Int J Dermatol. 37:860-9, 1998.
4. ) Nino M, Barberio E: Lupus miliaris disseminatus faciei and its debated link to tuberculosis. J Eur Acad Dermatol Venereol. 17:97-116, 2003.
5. ) Weakly DR: Lupus miliaris disseminatus faciei. In Dermis DJ. McGuire J (eds): Clinical Dermatology, 11th edn. Philadelphia: Harper & Row. Unit 16-26, 25, 1984.
6. ) Marks R, Wilkinson DS: Acne agminata. In Rook A, Wilkinson DS, Ebling FJG, Champion RH (eds): Textbook of Dermatology, 4th edn. Oxford: Blackwell Scientific Publications. Pp: 1616-1617, 1986.
7. ) Dekio S, Jidoi J, Imaoka C: Lupus miliaris disseminatus faciei report of a case in an elderly women. Clin Exp Dermatol. 16:295-6, 1991.
8. ) Lee DH, Li K, Suh DH: Pimecrolimus 1% cream for the treatment of steroid-induced rosacea: an 8-week split-face clinical trial. Br J Dermatol. 158(5):1069-76, 2008.

9. ) Chu CY: An open-label pilot study to evaluate the safety and efficacy of topically applied pimecrolimus cream for the treatment of steroid-induced rosacea-like eruption. J Eur Acad Dermatol Venereol. 21(4):484-90, 2007.
10. ) Egan CA, Rallis TM, Meadows KP, Krueger GG: Rosacea induced by beclomethasone dipropionate nasal spray. Int J Dermatol. 38(2):133-4, 1999.
11. ) Goss JM, Nord KM, Olarte MR, Grossman ME: Perioral dermatitis in a patient with myasthenia gravis following systemic corticosteroid treatment. Br J Dermatol. 156(3):582, 2007.
12. ) Adams SJ, Davison AM, Cunliffe WJ, Giles GR: Perioral dermatitis in renal transplant recipients maintained on corticosteroids and immunosuppressive therapy. Br J Dermatol. 106(5):589-92, 1982.